Dear Friends of the EBC,
The COVID-19 vaccination began last month in Japan and a few days ago, Japanese drugmaker Daiichi Sankyo Co. started manufacturing the AstraZeneca vaccine.
Last week was therefore a timely context for the EBC to hold its Briefing on COVID-19 Vaccines and Tests with Mr. Woxtröm, President of AstraZeneca Japan and Mr. Eda, Head – Portfolio and Life Cycle Management at Roche Diagnostics. I would like to warmly thank our two speakers for sharing their valuable experience with us. I invite you to read the summary of this event and Mr. Eda’s presentation, as well as a EuroBiz article about our Medical Equipment committee. If you wish to join it, please contact the EBC !
Finally, let me draw your attention to a JETRO Seminar on the 2021 Tax Reform, organised this afternoon. As the 2021 tax reform plan includes a wide range of revisions, such as an exemption from inheritance tax for certain foreign nationals staying in Japan for a long period of time and a major revision of the requirement to affix a seal to tax-related documents, this webinar will provide you important information!
Enjoy your reading,
We hope you stay positive and healthy during this difficult time.
Valerie Moschetti
EBC Chief Operating Officer |